De-escalation of corticosteroids and clonal remission in UBA1 mutation-driven VEXAS syndrome with 5-azacytidine.

Journal

Haematologica

ISSN: 1592-8721

Titre abrégé: Haematologica

Pays: Italy

ID NLM: 0417435

Informations de publication

Date de publication:
13 Jun 2024

Historique:

received: 22 03 2024

medline: 13 6 2024

pubmed: 13 6 2024

entrez: 13 6 2024

Statut: aheadofprint

Résumé

Not available.

Identifiants

DOI: 10.3324/haematol.2024.285519 PMID: 38867587

pubmed: 38867587

doi: 10.3324/haematol.2024.285519

doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Roochi Trikha (R)

Haematology Department, King's College Hospital NHS Foundation Trust, London.

Kar Lok Kong (KL)

Synnovis, Laboratory for Molecular Haemato-Oncology, King's College Hospital NHS Foundation Trust.

James Galloway (J)

Rheumatology Department, King's College Hospital NHS Foundation Trust, London.

Tanya N Basu (TN)

Dermatology Department, King's College Hospital NHS Foundation Trust, London.

Lynn Quek (L)

Haematology Department, King's College Hospital NHS Foundation Trust, London, UK; King's College London, London.

Jamie Wilson (J)

Department of Haematology, University Hospitals Sussex NHS Foundation Trust, Chichester.

Louise Gamble (L)

Clinical Haematology, Salisbury NHS Foundation Trust, Salisbury UK.

Henna Wong (H)

Department of Haematology, Hampshire Hospitals NHS Foundation Trust, Basingstoke.

Steven Best (S)